Advancing Cardiovascular Health: Therapeutic Potential of Nutrition and Herbal Remedies [0.03%]
心血管健康促进：营养和草药治疗的潜力
Sonia Singh,Ashima Ahuja
Sonia Singh
Introduction: Cardiovascular diseases are more prevalent and have created an alarming situation worldwide. Nutraceuticals are a class of nutrients that include common foods and fruits for managing various diseases. This p...
Evaluation of Angiotensin-converting Enzyme Inhibitory Potential of Seed Protein Hydrolysates from Muskmelon, Watermelon and Sunflower [0.03%]
评估甜瓜、西瓜和向日葵种子蛋白水解物的血管紧张素转换酶抑制潜力
Bassil Aljallah,Parimala Karthik,Bindhu Omana Sukumaran
Bassil Aljallah
Introduction: Antihypertensive treatments, including diuretics and beta/calcium channel blockers, are associated with a range of adverse effects. Naturally sourced ACE inhibitors may serve as viable alternatives to synthe...
Combining Atorvastatin with Dietary Agents to Manage Dyslipidaemia and Drug-induced Adverse Events: A First Reflective Narrative Review of Current Findings and Potential Directions [0.03%]
阿托伐他汀与饮食成分联合使用以管理脂质异常和药物不良事件：当前研究及潜在方向的首次反思性叙述性综述
Harshal S Mehta,Pankaj Prabhakar,Michael L J Pais et al.
Harshal S Mehta et al.
Hyperlipidemia-a metabolic disorder characterized by elevated levels of lipids such as cholesterol and triglycerides in the blood-is a growing global public health concern. It encompasses hypercholesterolemia, hypertriglyceridemia, mixed hy...
Chemical Synthesis and Biochemical Evaluation of Decasulfated Galloylglucopyranose Heparin Mimetic [0.03%]
十硫酸化没食子酸糖槐胶模拟物的化学合成及生化评价
Rami A Al-Horani
Rami A Al-Horani
Introduction: Thrombosis remains a major global health burden, necessitating safer and more effective antithrombotic strategies. Current therapies, including vitamin K antagonists, heparin derivatives, and direct oral ant...
Interactions Among Drugs, Food, Beverages, Alcohol, Herbs, Phytochemicals, Nutraceuticals, and Micronutrients: A Current and Updated Review [0.03%]
药物、食物、饮料、酒精、草药、植物化学物、营养补充剂和微量营养素之间的相互作用：最新综述
Zahra Tolou-Ghamari
Zahra Tolou-Ghamari
Introduction: Alterations in the pharmacokinetics or pharmacodynamics of a drug could be the result of interaction with nutritional elements or due to the nutritional status of patients. This review summarizes the finding...
Targeting Relapsed Multiple Myeloma with Elranatamab: A Bispecific Antibody Approach [0.03%]
靶向复发多发性骨髓瘤的Elranatamab：双特异性抗体疗法
Shivam Kumar,Arvind Kumar Patel,Dharmendra Kumar et al.
Shivam Kumar et al.
Elranatamab, an IgG2 bispecific antibody targeting B-cell maturation antigen (BCMA) and CD3 on T cells, is a promising therapeutic option for relapsed or refractory multiple myeloma (RRMM), a hematologic malignancy with limited therapeutic ...
Administration of Aspirin and Aqueous Leaf Extract of Terminalia Catappa Reduces Leukocytosis with Risk of Developing Thrombocytosis in Diabetic Wistar Rats [0.03%]
aspirin和Terminalia Catappa叶提取物通过降低白细胞计数并可能增加血小板计数来改善大鼠糖尿病炎症反应
Ezekiel Etim Ben,Justin Atiang Beshel,Asuquo Etim Asuquo et al.
Ezekiel Etim Ben et al.
Introduction: Leucocytosis, inflammation, and thrombocytosis are major risk factors for diabetes mellitus. This study investigates the effects of administering aspirin, meloxicam, or Terminalia catappa leaf extract on leu...
Therapeutic Strategies for Endothelial Dysfunction in Cardiovascular Disease, Rheumatoid Arthritis, and Diabetes: Current and Emerging Approaches [0.03%]
心血管疾病、类风湿关节炎和糖尿病内皮功能障碍的治疗策略：当前及新兴方法
Vikrant Verma
Vikrant Verma
The endothelium forms the inner vital lining of blood vessels and controls vascular tone, hemostasis, and inflammation, maintaining cardiovascular homeostasis. Endothelial dysfunction, characterized by abnormal vasodilation, increased oxida...
The Chemistry of Gliflozins: Recent Advancements in SGLT-2 Inhibitors [0.03%]
钠葡萄糖协同转运蛋白2抑制剂的研究进展：以恩格列净为例
Samman,Kuldeep Singh,Syed Misbahul Hasan et al.
Samman et al.
Approximately 422 million individuals worldwide have been diagnosed with Diabetes Mellitus (DM), a severe metabolic disorder, within the last 30 years. The chemical pharmacology of bexagliflozin, the most recent SGLT-2i, has been investigat...
Comparative Efficacy and Safety of Dabigatran, Enoxaparin, and Rivaroxaban for Prophylaxis of Cancer-associated Venous Thromboembolism: A Single-center Randomized Trial [0.03%]
达比加群、依诺肝素和利伐沙班预防癌症相关静脉血栓形成的疗效和安全性：单中心随机试验
Pouya Yousefli,Farahnaz Ghahremanfard,Masoumeh Masoudian et al.
Pouya Yousefli et al.
Introduction: The objective of this study was to compare the prophylactic efficacy of enoxaparin, dabigatran, and rivaroxaban in ambulatory patients with cancer. ...